Endothelial cell loss after descemet stripping with endothelial keratoplasty influencing factors and 2-year trend
- PMID: 17868873
- DOI: 10.1016/j.ophtha.2007.06.033
Endothelial cell loss after descemet stripping with endothelial keratoplasty influencing factors and 2-year trend
Abstract
Purpose: To identify factors correlated with early endothelial cell loss after Descemet stripping with endothelial keratoplasty (DSEK) and to document cell loss over a 2-year period.
Design: Cross-sectional and longitudinal retrospective analyses.
Participants: A series of 263 eyes in 216 patients who were treated with DSEK and were examined at the same center after surgery.
Methods: Six-month endothelial cell density (ECD) measurements were analyzed by multivariate analysis of variance to identify preoperative, operative, and postoperative factors that significantly influenced early cell loss. In addition, ECD measurements were compared longitudinally at 6, 12, and 24 months after grafting.
Main outcome measures: Central ECD after transplantation.
Results: Mean ECD was 2000+/-550 cells/mm(2) 6 months after DSEK, representing cell loss of 34+/-18%. Factors associated with lower 6-month cell loss were use of single-point fixation forceps that compressed the donor tissue only at the tip during graft insertion (P = 0.025) and absence of any secondary donor reattachment procedure (P = 0.035). Six-month cell loss also was significantly less when DSEK was performed as a combined procedure; in combined cases, the graft was inserted through a clear corneal incision, whereas in standard cases, it was inserted through a scleral tunnel incision, which likely exerted more compression. Cell loss was comparable with manual and microkeratome donor dissection techniques (P = 0.91). Postoperative ECD was correlated positively with donor ECD (P<0.0001) and was correlated inversely with donor age (P<0.0001), although these donor characteristics explained only 10% of the total variance in 6-month ECD. Factors not significantly correlated with 6-month ECD or cell loss included donor death-to-preservation time (range, 1-22 hours; P = 0.45), donor death-to-use time (range, 2-8 days; P = 0.86), and recipient demographics. In 34 DSEK eyes analyzed longitudinally, mean ECD was 3100+/-250 cells/mm(2) before surgery, 2000+/-540 cells/mm(2) at 6 months, 1900+/-480 cells/mm(2) at 1 year, and 1800+/-490 cells/mm(2) at 2 years.
Conclusions: Cell loss 6 months and 1 year after DSEK was higher than in a recent penetrating keratoplasty series performed at the same center, consistent with more donor tissue manipulation in DSEK. Cell loss was reduced with certain variations in surgical technique.
Comment in
-
Does endothelial cell survival differ between DSEK and standard PK?Ophthalmology. 2009 Mar;116(3):367-8. doi: 10.1016/j.ophtha.2008.11.017. Ophthalmology. 2009. PMID: 19264213 No abstract available.
Similar articles
-
Endothelial cell loss after Descemet's stripping endothelial keratoplasty in a large prospective series.Ophthalmology. 2008 Mar;115(3):488-496.e3. doi: 10.1016/j.ophtha.2007.10.035. Epub 2007 Dec 27. Ophthalmology. 2008. PMID: 18164063
-
Endothelial keratoplasty for Fuchs' dystrophy with cataract: complications and clinical results with the new triple procedure.Ophthalmology. 2009 Apr;116(4):631-9. doi: 10.1016/j.ophtha.2008.11.004. Epub 2009 Feb 8. Ophthalmology. 2009. PMID: 19201480
-
Experience and 12-month results of descemet-stripping endothelial keratoplasty (DSEK) with a small-incision technique.Cornea. 2007 Apr;26(3):279-83. doi: 10.1097/ICO.0b013e31802cd8c2. Cornea. 2007. PMID: 17413953
-
Descemet's stripping endothelial keratoplasty.Curr Opin Ophthalmol. 2007 Jul;18(4):290-4. doi: 10.1097/ICU.0b013e3281a4775b. Curr Opin Ophthalmol. 2007. PMID: 17568204 Review.
-
Descemet's stripping endothelial keratoplasty: safety and outcomes: a report by the American Academy of Ophthalmology.Ophthalmology. 2009 Sep;116(9):1818-30. doi: 10.1016/j.ophtha.2009.06.021. Epub 2009 Jul 30. Ophthalmology. 2009. PMID: 19643492 Review.
Cited by
-
Expression of Hormones' Receptors in Human Corneal Endothelium from Fuchs' Dystrophy: A Possible Gender' Association.J Clin Med. 2024 Jun 27;13(13):3787. doi: 10.3390/jcm13133787. J Clin Med. 2024. PMID: 38999352 Free PMC article.
-
Prospective evaluation of clinical outcomes between pre-cut corneal grafts prepared using a manual or automated technique: with one-year follow-up.Acta Ophthalmol. 2019 Nov;97(7):714-720. doi: 10.1111/aos.14074. Epub 2019 Feb 25. Acta Ophthalmol. 2019. PMID: 30803143 Free PMC article. Clinical Trial.
-
Graft survival and endothelial outcomes in the new era of endothelial keratoplasty.Exp Eye Res. 2012 Feb;95(1):40-7. doi: 10.1016/j.exer.2011.05.013. Epub 2011 Jun 15. Exp Eye Res. 2012. PMID: 21689649 Free PMC article. Review.
-
Complications and management in Descemet's stripping endothelial keratoplasty: analysis of consecutive 430 cases.Indian J Ophthalmol. 2014 Feb;62(2):209-18. doi: 10.4103/0301-4738.116484. Indian J Ophthalmol. 2014. PMID: 24008797 Free PMC article.
-
Corneal Endothelial Cell Loss 3 Years After Successful Descemet Stripping Automated Endothelial Keratoplasty in the Cornea Preservation Time Study: A Randomized Clinical Trial.JAMA Ophthalmol. 2017 Dec 1;135(12):1394-1400. doi: 10.1001/jamaophthalmol.2017.4970. JAMA Ophthalmol. 2017. PMID: 29127432 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical